Agriculture-focused data science company Fermata secured $10 million while vertical farming company Plenty faces a value cut.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cencora (COR – Research Report) and Inari ...

Inari Medical (NASDAQ:NARI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by Robert W. Baird in a research note issued to investors on Tuesday,Benzinga reports. They presently have a ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.